missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18187635

VSIG2 Antibody (OTI2D8), Alexa Fluor™ 700, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-74858AF700

Product Code. 18187635

  • € 785.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

VSIG2 Monoclonal specifically detects VSIG2 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

VSIG2
Monoclonal
Alexa Fluor 700
50mM Sodium Borate with 0.05% Sodium Azide
VSIG2
Full length recombinant protein of human VSIG2 (NP_055127) produced in HEK293T cells.
0.1 mL
23584.0
Store at 4°C in the dark.
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI2D8
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
2210413P10Rik, Cortical thymocyte-like protein, CTHCTXLcortical thymocyte receptor (X. laevis CTX) like, CT-like protein, V-set and immunoglobulin domain containing 2, V-set and immunoglobulin domain-containing protein 2
Mouse
Affinity Purified
Primary
Human
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.